Editas Medicine Stock Price on December 16, 2024
| EDIT Stock | USD 1.31 0.03 2.24% |
Below is the normalized historical share price chart for Editas Medicine extending back to February 03, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Editas Medicine stands at 1.31, as last reported on the 22nd of December, with the highest price reaching 1.38 and the lowest price hitting 1.28 during the day.
If you're considering investing in Editas Stock, it is important to understand the factors that can impact its price. Editas Medicine secures Sharpe Ratio (or Efficiency) of -0.26, which denotes the company had a -0.26% return per unit of risk over the last 3 months. Editas Medicine exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Editas Medicine's Variance of 29.69, mean deviation of 3.78, and Standard Deviation of 5.45 to check the risk estimate we provide.
At this time, Editas Medicine's Other Stockholder Equity is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 21.3 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 239.8 M in 2024. . At this time, Editas Medicine's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.31 in 2024, whereas Price Earnings To Growth Ratio is likely to drop 0.15 in 2024. Editas Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of February 2016 | 200 Day MA 4.585 | 50 Day MA 2.6363 | Beta 2.006 |
Editas |
Sharpe Ratio = -0.2576
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EDIT |
Estimated Market Risk
| 5.48 actual daily | 48 52% of assets are more volatile |
Expected Return
| -1.41 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.26 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Editas Medicine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Editas Medicine by adding Editas Medicine to a well-diversified portfolio.
Price Book 0.6157 | Enterprise Value Ebitda (1.36) | Price Sales 1.751 | Shares Float 76.2 M | Wall Street Target Price 3.6667 |
Related Headline
Caribou Biosciences Headline on 16th of December 2024
Caribou Biosciences May Find a Bottom Soon, Heres Why You Sh... by finance.yahoo.com
Caribou Biosciences appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stocks potential for a turnaround in the near term.
Editas Medicine Valuation on December 16, 2024
It is possible to determine the worth of Editas Medicine on a given historical date. On December 16, 2024 Editas was worth 1.44 at the beginning of the trading date compared to the closed value of 1.48. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Editas Medicine stock. Still, in general, we apply an absolute valuation method to find Editas Medicine's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Editas Medicine where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Editas Medicine's related companies.
| Open | High | Low | Close | Volume | |
| 1.75 | 1.77 | 1.41 | 1.44 | 10,550,836 | |
12/16/2024 | 1.44 | 1.61 | 1.39 | 1.48 | 4,989,748 |
| 1.50 | 1.55 | 1.44 | 1.52 | 2,862,877 |
| Backtest Editas Medicine | | | Editas Medicine History | | | Editas Medicine Valuation | Previous | Next |
Editas Medicine Trading Date Momentum on December 16, 2024
| On December 17 2024 Editas Medicine was traded for 1.52 at the closing time. The top price for the day was 1.55 and the lowest listed price was 1.44 . The trading volume for the day was 2.9 M. The trading history from December 17, 2024 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 2.70% . The overall trading delta against the current closing price is 10.14% . |
Editas Medicine Fundamentals Correlations and Trends
By evaluating Editas Medicine's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Editas Medicine's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Editas financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Editas Medicine Stock history
Editas Medicine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Editas is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Editas Medicine will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Editas Medicine stock prices may prove useful in developing a viable investing in Editas Medicine
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 76 M | 49.3 M | |
| Net Loss | -198.4 M | -188.5 M |
Editas Medicine Quarterly Net Working Capital |
|
Editas Medicine Stock Technical Analysis
Editas Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Editas Medicine Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Editas Medicine cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Editas Medicine December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Editas Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Editas Medicine shares will generate the highest return on investment. By undertsting and applying Editas Medicine stock market strength indicators, traders can identify Editas Medicine entry and exit signals to maximize returns
Editas Medicine Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Editas Medicine's price direction in advance. Along with the technical and fundamental analysis of Editas Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Editas to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.21) | |||
| Jensen Alpha | (1.55) | |||
| Total Risk Alpha | (1.65) | |||
| Treynor Ratio | (0.63) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Editas Stock Analysis
When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.